NERV MINERVA NEUROSCIENCES INC revenue, earnings and financials
For the quarter ended June 30, 2026, MINERVA NEUROSCIENCES INC reported revenue of n/a, net income of $17.5M and diluted EPS of −$0.14; for the fiscal year ended December 2025 revenue was n/a.
NERV annual revenue and earnings
- Fiscal year ended Dec 2025: revenue n/a, gross profit n/a, operating income −$15.1M, net income −$293M (margin n/a), EPS −$34.67
- Fiscal year ended Dec 2024: revenue $0, gross profit n/a, operating income −$21.8M, net income $1.44M (margin n/a), EPS $0.19
- Fiscal year ended Dec 2023: revenue $0, gross profit n/a, operating income −$23.1M, net income −$30.0M (margin n/a), EPS −$4.61
- Fiscal year ended Dec 2022: revenue $0, gross profit n/a, operating income −$25.2M, net income −$32.1M (margin n/a), EPS −$6.01
- Fiscal year ended Dec 2021: revenue $0, gross profit n/a, operating income −$45.4M, net income −$49.9M (margin n/a), EPS −$9.35
NERV quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income $17.5M, EPS −$0.14
- Quarter ended Mar 31, 2026: revenue n/a, net income −$125M, EPS −$2.86
- Quarter ended Dec 31, 2025 (from the annual report): revenue n/a, net income −$284M, EPS −$33.38
- Quarter ended Sep 30, 2025: revenue n/a, net income −$2.74M, EPS −$0.36
- Quarter ended Jun 30, 2025: revenue n/a, net income −$3.26M, EPS −$0.43
- Quarter ended Mar 31, 2025: revenue n/a, net income −$3.75M, EPS −$0.50
- Quarter ended Dec 31, 2024 (from the annual report): revenue n/a, net income −$4.27M, EPS −$0.56
- Quarter ended Sep 30, 2024: revenue n/a, net income $22.5M, EPS $2.97
- Quarter ended Jun 30, 2024: revenue n/a, net income −$8.23M, EPS −$1.09
- Quarter ended Mar 31, 2024: revenue n/a, net income −$8.57M, EPS −$1.13
- Quarter ended Dec 31, 2023 (from the annual report): revenue n/a, net income −$9.02M, EPS −$1.15
- Quarter ended Sep 30, 2023: revenue n/a, net income −$7.82M, EPS −$1.03
- Quarter ended Jun 30, 2023: revenue n/a, net income −$6.19M, EPS −$1.12
- Quarter ended Mar 31, 2023: revenue n/a, net income −$6.97M, EPS −$1.31
- Quarter ended Dec 31, 2022 (from the annual report): revenue n/a, net income −$6.73M, EPS −$1.26
- Quarter ended Sep 30, 2022: revenue n/a, net income −$6.90M, EPS −$1.29
- Quarter ended Jun 30, 2022: revenue n/a, net income −$8.72M, EPS −$1.63
- Quarter ended Mar 31, 2022: revenue n/a, net income −$9.76M, EPS −$1.83
- Quarter ended Dec 31, 2021 (from the annual report): revenue n/a, net income −$21.3M, EPS −$7.17
- Quarter ended Sep 30, 2021: revenue n/a, net income −$9.21M, EPS −$1.72
NERV cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$13.5M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$19.6M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$14.8M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$24.6M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$24.6M, share buybacks n/a
NERV balance sheet
- Jun 30, 2026: cash $24.7M, total assets $95.1M, total liabilities $297M, shareholders' equity −$213M
- Mar 31, 2026: cash $32.7M, total assets $94.0M, total liabilities $343M, shareholders' equity −$254M
- Dec 31, 2025: cash $82.3M, total assets $98.0M, total liabilities $234M, shareholders' equity −$141M
- Sep 30, 2025: cash $12.3M, total assets $28.1M, total liabilities $62.7M, shareholders' equity −$34.6M
- Jun 30, 2025: cash $15.2M, total assets $30.4M, total liabilities $62.5M, shareholders' equity −$32.1M
- Mar 31, 2025: cash $17.3M, total assets $32.8M, total liabilities $61.9M, shareholders' equity −$29.1M
- Dec 31, 2024: cash $21.4M, total assets $37.1M, total liabilities $62.8M, shareholders' equity −$25.7M
- Sep 30, 2024: cash $26.5M, total assets $42.8M, total liabilities $64.5M, shareholders' equity −$21.7M
Is NERV profitable?
No. MINERVA NEUROSCIENCES INC lost $394M over the last four quarters.
What is NERV's EPS?
Diluted earnings per share over the last four quarters were −$36.74; −$0.14 in the latest quarter.